Shaman Pharmaceuticals Inc. said it completed an initial publicoffering of 3 million shares of common stock at $15 per share,an increase of 500,000 shares from the preliminary prospectus.
The underwriters retain an option to purchase 450,000 sharesto cover any overallotments.
The San Carlos, Calif., company (NASDAQ:SHMN) developstraditional pharmaceuticals through isolating active compoundsfrom tropical plants with a history of medicinal use.
(c) 1997 American Health Consultants. All rights reserved.